Clinical Trial

"Walking Together with Love": a Couples-Based Intervention for Sexual and Relationship Distress in Cancer Patients

Study acronym: WTL
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2025 (before its estimated October 26, 2025 completion). Its status may not reflect the trial's current state.
Summary
Cancer diagnosis and treatment often result in significant changes in body appearance, sexual functioning, and relationship quality, leading to distress for both patients and their partners. To address these challenges, a comprehensive intervention program called "Walking Together with Love" (WTL) has been developed. This intervention focuses on three key areas: improving body image (supporting patients in accepting physical changes after cancer treatment), enhancing psychological flexibility (enabling patients and partners to openly and positively manage difficult experiences), and strengthening dyadic coping skills (promoting effective communication and emotional support between partners). The primary aim of this intervention is to reduce sexual and relationship distress among cancer patients and their partners. WTL is a six-week program consisting of weekly 90- to 120-minute sessions delivered in a hybrid format (both online and offline). Sessions incorporate psychoeducational presentations, group discussions, professional guidance, and structured home assignments. Both patients and their partners participate together, collaboratively working toward improving relationship quality and overall well-being. Cancer patients, their partners, and healthcare providers are encouraged to learn more about this research project and explore its potential benefits in improving quality of life for couples affected by cancer.
Trial Details
NCT Number NCT06906575
Lead Sponsor Yanfei Jin
Conditions Sexual Dysfunction, Psychological, Relationship Distress, Cancer
Enrollment 100 participants
Start Date 2025-04-01
Primary Completion 2025-10-26 (estimated)
Study Completion 2025-10-26 (estimated)
Updated on ClinicalTrials.gov 2025-04-02